Information:
Fel:
ID
34417
Beskrivning
Non-isotope Based Imaging Modalities vs Technetium-99m Single-Photon Emission Computed Tomography(99mTcSPECT); ODM derived from: https://clinicaltrials.gov/show/NCT01972360
Länk
https://clinicaltrials.gov/show/NCT01972360
Nyckelord
Versioner (1)
- 2019-01-17 2019-01-17 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
17 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Myocardial Ischemia NCT01972360
Eligibility Myocardial Ischemia NCT01972360
- StudyEvent: Eligibility
Similar models
Eligibility Myocardial Ischemia NCT01972360
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
clinically indicated request for spect
boolean
ID.2
Item
ability to undergo at least one of three non-nuclear imaging tests; cmr, ct or stress echocardiography
boolean
ID.3
Item
history of recent symptoms suggestive of myocardial ischemia
boolean
ID.4
Item
high risk for ischemic cardiovascular events
boolean
ID.5
Item
severely reduced systolic function (lv ejection fraction less than 35%)
boolean
ID.6
Item
recent (less than 3 days) acute coronary syndrome including acute myocardial infarction
boolean
ID.7
Item
contraindications to dipyridamole spect including : i)severe reactive airway disease; ii) less than 3 days post myocardial infarction - acute coronary syndrome (mi-acs); iii) high-grade atrioventricular block (av block); iv)allergy to dipyridamole or theophylline; v) caffeine within 12 hours; vi) theophylline use within 48 hours; vii) severe claustrophobia; or viii) women who may be pregnant
boolean
ID.8
Item
kidney dysfunction (i.e estimated glomerular filtration rate (egfr) less than 45)
boolean
ID.9
Item
use of investigational drug or device within 30 days of screening visit
boolean